Medicare Enrolled
Dr. Asad Sawar, MD
Cardiovascular Disease · Tampa, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sawar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sawar? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sawar
Dr. Asad Sawar is a cardiovascular disease in Tampa, FL, with 20 years in practice. Based on federal Medicare data, Dr. Sawar performed 7,005 Medicare services across 3,505 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sawar received a total of $20,529 from 71 pharmaceutical and/or device companies across 711 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sawar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 13% volume in FL$ $20,529 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,005
Medicare services
Top 13% in FL for cardiovascular disease
3,505
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~350 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 1,539 | $67 | $146 |
| Hospital follow-up visit, moderate complexity | 1,423 | $64 | $147 |
| Hospital follow-up visit, low complexity | 1,197 | $40 | $80 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 303 | $28 | $72 |
| Remote pacemaker/defibrillator monitoring, 90 days | 236 | $17 | $51 |
| Hospital follow-up visit, high complexity | 216 | $96 | $213 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 168 | $21 | $55 |
| Remote pacemaker monitoring, 90 days | 166 | $23 | $69 |
| EKG interpretation and report | 152 | $6 | $75 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 139 | $20 | $54 |
| New patient office visit (30-44 min) | 128 | $80 | $218 |
| Regadenoson injection (Lexiscan) for heart stress test | 124 | $32 | $190 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 107 | $9 | $32 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 107 | $19 | $54 |
| Evaluation of implantable heart and blood vessel monitoring system | 106 | $17 | $44 |
| Echocardiogram, transthoracic | 106 | $143 | $449 |
| Programming of dual lead pacemaker system | 81 | $29 | $78 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 70 | $29 | $138 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 44 | $90 | $236 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 42 | $10 | $101 |
| Ultrasound of heart, follow-up | 37 | $20 | $53 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 36 | $340 | $954 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 36 | $49 | $152 |
| Programming of multiple lead implantable defibrillator system | 31 | $48 | $128 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 28 | $360 | $852 |
| Programming of cardiac rhythm monitor system | 25 | $20 | $53 |
| Ultrasound of both sides of head and neck blood flow | 24 | $143 | $398 |
| Cardiac catheterization | 23 | $210 | $642 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 22 | $842 | $3,002 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 22 | $21 | $53 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $169 | $534 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 22 | $146 | $387 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 21 | $135 | $398 |
| Electrocardiogram (EKG), 12-lead | 19 | $11 | $34 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $85 | $223 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $14 | $37 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $2 | $6 |
| Ultrasound of leg arteries or artery grafts | 17 | $171 | $508 |
| Office visit, established patient (30-39 min) | 16 | $89 | $215 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $17 | $45 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $11 | $30 |
| Office visit, established patient (10-19 min) | 14 | $29 | $87 |
| Heart rhythm recording of continous external ekg over 8-15 days | 13 | $9 | $32 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 13 | $19 | $59 |
| Coronary stent placement | 12 | $449 | $1,286 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $142 | $376 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.0% high complexity
5.6% medium
83.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,529
Total received (2018-2024)
Avg $2,933/year across 7 years
Top 14% in FL for cardiovascular disease
71
Companies
711
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,004 (73.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,525 (26.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,403
2023$2,580
2022$2,232
2021$3,258
2020$2,673
2019$3,530
2018$3,853
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$4,359
Penumbra, Inc.
$1,547
Cook Incorporated
$1,522
PFIZER INC.
$1,055
BIOTRONIK INC.
$950
Novartis Pharmaceuticals Corporation
$908
CVRx, Inc.
$806
Cook Medical LLC
$686
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$577
SANOFI-AVENTIS U.S. LLC
$531
E.R. Squibb & Sons, L.L.C.
$513
Medtronic, Inc.
$459
Boston Scientific Corporation
$397
Inari Medical, Inc.
$386
Boehringer Ingelheim Pharmaceuticals, Inc.
$379
Janssen Pharmaceuticals, Inc
$350
Impulse Dynamics (USA) Inc.
$293
Bayer HealthCare Pharmaceuticals Inc.
$267
Lundbeck LLC
$253
Cardiovascular Systems Inc.
$235
Merck Sharp & Dohme LLC
$225
ShockWave Medical, Inc
$218
ABIOMED
$217
Medtronic Vascular, Inc.
$209
Abbott Laboratories
$185
Alnylam Pharmaceuticals Inc.
$169
Lexicon Pharmaceuticals, Inc.
$166
EKOS Corporation
$162
Actelion Pharmaceuticals US, Inc.
$157
AngioDynamics, Inc.
$157
Amarin Pharma Inc.
$150
Amgen Inc.
$143
W. L. Gore & Associates, Inc.
$126
ACIST MEDICAL SYSTEMS, INC.
$121
Novo Nordisk Inc
$119
BARD PERIPHERAL VASCULAR, INC.
$100
Regeneron Healthcare Solutions, Inc.
$96
LANTHEUS MEDICAL IMAGING, INC.
$90
Philips Electronics North America Corporation
$88
Gilead Sciences, Inc.
$81
Kestra Medical Technology Services, Inc.
$69
Astellas Pharma US Inc
$68
Esperion Therapeutics, Inc.
$67
Vital Connect, Inc
$65
PORTOLA PHARMACEUTICALS, INC.
$54
Baxter Healthcare
$52
Chiesi USA, Inc.
$46
Acutus Medical, Inc.
$43
La Jolla Pharmaceutical Company
$40
ATRICURE, INC.
$40
Kiniksa Pharmaceuticals, Ltd.
$40
Bayer Healthcare Pharmaceuticals Inc.
$39
Ethicon US, LLC
$36
Kiniksa Pharmaceuticals International, plc
$35
Kowa Pharmaceuticals America, Inc.
$35
BOSTON SCIENTIFIC CORPORATION
$34
Quidel Corporation
$34
ARALEZ PHARMACEUTICALS US INC.
$33
CMS Imaging, Inc.
$31
GENZYME CORPORATION
$28
SCPHARMACEUTICALS INC.
$27
ARGON MEDICAL DEVICES, INC.
$22
Aziyo Biologics, Inc.
$21
United Therapeutics Corporation
$18
Tactile Systems Technology Inc
$16
CHIESI USA, INC.
$15
C. R. BARD, INC. & SUBSIDIARIES
$14
HeartFlow, Inc.
$14
LivaNova USA, Inc.
$14
Coala Life Inc
$13
GE Healthcare
$11
Top 3 companies account for 36.2% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Extended Holter · ANDEXXA · ANGIOJET · AURYON LASER SYSTEM 100-120 VAC · Adempas · Arcalyst · Assure WCD · Astron; Pulsar; AstronPulsar · BEVYXXA · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CELEBREX · CHANTIX · CLEVIPREX · CLOSUREFAST · COOK MEDICAL ANGIOPLASTY · COOK MEDICAL CATHETERS · COOK MEDICAL FILTERS · COOK MEDICAL IAA · COOK MEDICAL STENTS · COOK MEDICAL WIRE GUIDES · COOK MEDICAL ZILVER PTX · COREVALVE EVOLUT R · CVI SYSTEMS · CardioMEMS HF System · Coala Heart Monitor · Confirm Rx · Cook Medical Angioplasty · Cook Medical Catheters · Cook Medical Self-Expanding Stent · Cook Medical Stents · Cook Medical Zilver · Cook Medical Zilver PTX · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DEFINITY · DIAMONDBACK CORONARY · Diamondback Coronary · Diamondback Peripheral · ECM Patch · EKOSONIC · ELIQUIS · EMBLEM · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edora · Ellipse ICD · FARXIGA · FLEXITOUCH · FLOWTRIEVER CATHETER · FUROSCIX · FlowTriever · Fortify Assura · GENERAL ANGIOPLASTY · GENERAL VASCULAR INTERVENTION · GENERAL - THERAPIES · GIAPREZA · GORE CARDIOFORM Septal Occluder · HAWKONE · Hillrom - Cardiac Ambulatory Monitor · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · LATITUDE · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · Lunderquist · MICRA · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Optis Coronary Imaging System · Orsiro Mission · Ozempic · PK Papyrus · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · Pouch · ProtekDuo Kit · Pulsar · RESONATE · RXI CONSUMABLES · RXI SYSTEMS · RYBELSUS · Repatha · Resolute · Reveal LINQ · Rybelsus · S · S-ICD System Magnet · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Surgicel Powder · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · THROMBECTOMY · TYVASO · Torcon NB · Triage · UPTRAVI · VENACURE 1470 PRO · VENASEAL · VERQUVO · VIABAHN VBX Balloon Expandable Endoprosthesis · VITALPATCH RTM · VYNDAQEL · Varithena Administration Pack · Vascepa · Verquvo · WATCHMAN · WATCHMAN FLX · XARELTO · ZILVER PTX · ZONTIVITY · Zilver PTX · Zilver Vena
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $293 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
225
Per 100K population
15.1
County median income
$75,011
Nearest hospital
ADVENTHEALTH TAMPA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sawar is a clinical cardiology specialist, with above-average Medicare volume (top 13% in FL), and high industry engagement (low-engagement, top 14%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sawar experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Sawar performed 1,539 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sawar receive payments from pharmaceutical companies?
Yes. Dr. Sawar received a total of $20,529 from 71 companies across 711 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sawar's costs compare to other cardiovascular diseases in Tampa?
Dr. Sawar's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sawar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Tampa
Browse cardiovascular diseases in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc..
By company
Cook Incorporated Payments to Doctors
See all physicians who received payments from Cook Incorporated.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology